Hancock Jaffe Laboratories Inc (HJLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | HJLI | SCYX | ARYD | ||
Company | Hancock Jaffe Laboratories Inc | Scynexis Inc | Arya Sciences Acquisition Corp IV Cl A | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 10.71 | 2.55 | 11.37 | ||
High | 10.75 | 2.90 | 11.40 | ||
Low | 10.26 | 2.46 | 11.37 | ||
Last | 10.38 | 2.77 | 11.40 | ||
Change | -0.21 | +0.36 | +0.03 | ||
% Change | -1.98% | +14.94% | +0.26% | ||
Volume | 221,800 | 902,600 | 2,800 | ||
20-Day Average Volume | 295,705 | 299,350 | 16,880 | ||
Previous Close | 10.59 | 2.41 | 11.37 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | No | ||
Technicals | |||||
20-Day Moving Average | 9.16 | 1.85 | 11.33 | ||
20-Day Raw Stochastic | 73.54% | 91.22% | 100.00% | ||
20-Day Relative Strength | 67.86% | 78.12% | 66.53% | ||
Weighted Alpha | +9.05 | +7.06 | +9.19 | ||
Today's Opinion | 88% Buy | 24% Buy | 100% Buy | ||
Previous Opinion | 88% Buy | 24% Buy | 100% Buy | ||
Last Month's Opinion | 40% Buy | 100% Sell | 96% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +7.34% since 09/23/21 | +42.78% since 05/10/24 | +0.44% since 05/01/24 | ||
Low | 9.49 on 09/24/21 | 1.84 on 05/14/24 | 11.35 on 05/09/24 | ||
High | 11.38 on 09/29/21 | 2.90 on 05/17/24 | 11.40 on 05/17/24 | ||
1-Month | |||||
%Chg | +34.98% since 08/30/21 | +95.07% since 04/17/24 | +0.80% since 04/16/24 | ||
Low | 7.60 on 09/07/21 | 1.39 on 04/19/24 | 11.33 on 04/25/24 | ||
High | 11.38 on 09/29/21 | 2.90 on 05/17/24 | 11.40 on 05/17/24 | ||
3-Month | |||||
%Chg | +51.09% since 06/30/21 | +61.05% since 02/16/24 | +1.51% since 02/16/24 | ||
Low | 5.36 on 07/19/21 | 1.35 on 03/19/24 | 11.16 on 02/23/24 | ||
High | 11.38 on 09/29/21 | 2.90 on 05/17/24 | 11.40 on 05/17/24 | ||
6-Month | |||||
%Chg | +62.70% since 03/30/21 | +70.99% since 11/17/23 | +4.97% since 11/17/23 | ||
Low | 4.99 on 05/13/21 | 1.35 on 03/19/24 | 10.85 on 12/29/23 | ||
High | 11.38 on 09/29/21 | 2.90 on 05/17/24 | 11.40 on 05/17/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 90,146 | 91,050 | 85,690 | ||
Shares Outstanding, K | 8,685 | 37,780 | 7,536 | ||
Annual Sales | 0 | 140,140,000 | 0 | ||
Annual Net Income | -9,140,000 | 67,040,000 | -2,130,000 | ||
Last Quarter Sales | 0 | 1,370,000 | 0 | ||
Last Quarter Net Income | -2,380,000 | 410,000 | -2,220,000 | ||
60-Month Beta | 1.51 | 1.49 | -0.01 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.15 on 05/08/24 | N/A | ||
Latest Earnings Date | 11/16/21 | 05/09/24 | N/A | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 1.20 | 0.00 |